

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | neutrophil activation involved in immune response (GO:0002283) | 4.99158150 |
| 2 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.96474437 |
| 3 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.93340962 |
| 4 | negative regulation of cell killing (GO:0031342) | 4.93340962 |
| 5 | * response to peptidoglycan (GO:0032494) | 4.67486602 |
| 6 | positive regulation by symbiont of host defense response (GO:0052509) | 4.64097310 |
| 7 | modulation by symbiont of host defense response (GO:0052031) | 4.64097310 |
| 8 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.64097310 |
| 9 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.64097310 |
| 10 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.64097310 |
| 11 | modulation by symbiont of host immune response (GO:0052553) | 4.64097310 |
| 12 | microglial cell activation (GO:0001774) | 4.56708808 |
| 13 | detection of bacterium (GO:0016045) | 4.46585481 |
| 14 | respiratory burst (GO:0045730) | 4.41115160 |
| 15 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.34178661 |
| 16 | immunoglobulin mediated immune response (GO:0016064) | 4.34038409 |
| 17 | leukocyte aggregation (GO:0070486) | 4.21951883 |
| 18 | macrophage activation (GO:0042116) | 4.07306643 |
| 19 | detection of biotic stimulus (GO:0009595) | 4.06667375 |
| 20 | hydrogen peroxide biosynthetic process (GO:0050665) | 4.05651160 |
| 21 | reactive oxygen species biosynthetic process (GO:1903409) | 3.99618754 |
| 22 | granulocyte activation (GO:0036230) | 3.88732126 |
| 23 | neutrophil activation (GO:0042119) | 3.82650868 |
| 24 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.81853585 |
| 25 | neutrophil mediated immunity (GO:0002446) | 3.79770647 |
| 26 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.75030892 |
| 27 | B cell mediated immunity (GO:0019724) | 3.74829763 |
| 28 | positive regulation of chemokine biosynthetic process (GO:0045080) | 3.65525747 |
| 29 | regulation of chemokine biosynthetic process (GO:0045073) | 3.61265072 |
| 30 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.59344091 |
| 31 | defense response to protozoan (GO:0042832) | 3.58117792 |
| 32 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.57552278 |
| 33 | response to interferon-alpha (GO:0035455) | 3.56634470 |
| 34 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.56129208 |
| 35 | superoxide anion generation (GO:0042554) | 3.55844018 |
| 36 | NIK/NF-kappaB signaling (GO:0038061) | 3.55593682 |
| 37 | macrophage activation involved in immune response (GO:0002281) | 3.53108496 |
| 38 | negative regulation of T cell mediated immunity (GO:0002710) | 3.52306783 |
| 39 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.50994677 |
| 40 | response to host immune response (GO:0052572) | 3.49537449 |
| 41 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.49537449 |
| 42 | regulation of leukocyte degranulation (GO:0043300) | 3.48667370 |
| 43 | response to muramyl dipeptide (GO:0032495) | 3.46485570 |
| 44 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.46284824 |
| 45 | B cell receptor signaling pathway (GO:0050853) | 3.42586092 |
| 46 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.39875712 |
| 47 | positive regulation of mast cell degranulation (GO:0043306) | 3.39875712 |
| 48 | response to protozoan (GO:0001562) | 3.38948032 |
| 49 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.37841303 |
| 50 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.37841303 |
| 51 | positive regulation of interferon-alpha production (GO:0032727) | 3.36355957 |
| 52 | negative regulation of viral genome replication (GO:0045071) | 3.36326487 |
| 53 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.35368023 |
| 54 | T-helper 1 type immune response (GO:0042088) | 3.31880400 |
| 55 | regulation of mast cell degranulation (GO:0043304) | 3.31720385 |
| 56 | regulation of podosome assembly (GO:0071801) | 3.30830132 |
| 57 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.30178612 |
| 58 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.28038150 |
| 59 | germinal center formation (GO:0002467) | 3.24367212 |
| 60 | regulation of interferon-alpha production (GO:0032647) | 3.23281081 |
| 61 | myeloid cell activation involved in immune response (GO:0002275) | 3.21771398 |
| 62 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.21649233 |
| 63 | response to host (GO:0075136) | 3.21649233 |
| 64 | response to host defenses (GO:0052200) | 3.21649233 |
| 65 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.20978894 |
| 66 | positive regulation of B cell differentiation (GO:0045579) | 3.19210629 |
| 67 | positive regulation of mast cell activation (GO:0033005) | 3.18656900 |
| 68 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.16692070 |
| 69 | response to interferon-beta (GO:0035456) | 3.16435204 |
| 70 | regulation of mast cell activation (GO:0033003) | 3.14225531 |
| 71 | leukocyte mediated cytotoxicity (GO:0001909) | 3.14075223 |
| 72 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 3.12619977 |
| 73 | cellular extravasation (GO:0045123) | 3.12616679 |
| 74 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.11605319 |
| 75 | leukocyte degranulation (GO:0043299) | 3.09424204 |
| 76 | regulation of gamma-delta T cell activation (GO:0046643) | 3.09010837 |
| 77 | myeloid dendritic cell differentiation (GO:0043011) | 3.08597245 |
| 78 | * negative regulation of interleukin-12 production (GO:0032695) | 3.08532772 |
| 79 | type I interferon signaling pathway (GO:0060337) | 3.08154920 |
| 80 | cellular response to type I interferon (GO:0071357) | 3.08154920 |
| 81 | myeloid dendritic cell activation (GO:0001773) | 3.08095716 |
| 82 | response to type I interferon (GO:0034340) | 3.07767213 |
| 83 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 3.06664903 |
| 84 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.05056702 |
| 85 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 3.04623353 |
| 86 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.04469059 |
| 87 | detection of other organism (GO:0098543) | 3.03757932 |
| 88 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.98282904 |
| 89 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.97483276 |
| 90 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.97402326 |
| 91 | myeloid leukocyte mediated immunity (GO:0002444) | 2.96713203 |
| 92 | detection of molecule of bacterial origin (GO:0032490) | 2.95707716 |
| 93 | regulation of regulated secretory pathway (GO:1903305) | 2.95165688 |
| 94 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.94753376 |
| 95 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 2.92745824 |
| 96 | positive regulation of heat generation (GO:0031652) | 2.91698612 |
| 97 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.91644461 |
| 98 | neutrophil chemotaxis (GO:0030593) | 2.91501227 |
| 99 | myeloid leukocyte activation (GO:0002274) | 2.90254362 |
| 100 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.89377891 |
| 101 | natural killer cell mediated immunity (GO:0002228) | 2.89377891 |
| 102 | negative regulation of interleukin-17 production (GO:0032700) | 2.87647164 |
| 103 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.87645089 |
| 104 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 2.87632244 |
| 105 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.87571989 |
| 106 | positive thymic T cell selection (GO:0045059) | 2.87000025 |
| 107 | neutrophil migration (GO:1990266) | 2.84081344 |
| 108 | response to fungus (GO:0009620) | 2.82785289 |
| 109 | regulation of B cell differentiation (GO:0045577) | 2.81985667 |
| 110 | negative regulation of growth of symbiont in host (GO:0044130) | 2.81157195 |
| 111 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 2.81157195 |
| 112 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 2.81157195 |
| 113 | regulation of growth of symbiont in host (GO:0044126) | 2.81157195 |
| 114 | mature B cell differentiation (GO:0002335) | 2.81090647 |
| 115 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.79498045 |
| 116 | cytokine secretion (GO:0050663) | 2.78235425 |
| 117 | response to interleukin-15 (GO:0070672) | 2.77274107 |
| 118 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.77248150 |
| 119 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.77248150 |
| 120 | mast cell activation (GO:0045576) | 2.77196284 |
| 121 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.76553464 |
| 122 | regulation of fever generation (GO:0031620) | 2.76406729 |
| 123 | positive regulation of leukocyte degranulation (GO:0043302) | 2.75504086 |
| 124 | detection of external biotic stimulus (GO:0098581) | 2.75393473 |
| 125 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.75111678 |
| 126 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.74844879 |
| 127 | regulation of interleukin-6 biosynthetic process (GO:0045408) | 2.74816129 |
| 128 | positive regulation of interferon-beta production (GO:0032728) | 2.74622330 |
| 129 | T cell migration (GO:0072678) | 2.74290022 |
| 130 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.74095110 |
| 131 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.72693238 |
| 132 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.71575475 |
| 133 | leukocyte cell-cell adhesion (GO:0007159) | 2.70930316 |
| 134 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.70902117 |
| 135 | positive regulation of antigen processing and presentation (GO:0002579) | 2.70128911 |
| 136 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.69666580 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.47169083 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 5.02257113 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.76334954 |
| 4 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 3.63855251 |
| 5 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.62514895 |
| 6 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.62062828 |
| 7 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.44399957 |
| 8 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.21513630 |
| 9 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.17312917 |
| 10 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.08134658 |
| 11 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.94410151 |
| 12 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.94303249 |
| 13 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.93886381 |
| 14 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.70336935 |
| 15 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.68927437 |
| 16 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.59473123 |
| 17 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.56919606 |
| 18 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.42768956 |
| 19 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.40905288 |
| 20 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.36175052 |
| 21 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.35123118 |
| 22 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.29454336 |
| 23 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.24555024 |
| 24 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.20028258 |
| 25 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.16006609 |
| 26 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.13182806 |
| 27 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.09257358 |
| 28 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.06515398 |
| 29 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 2.02158737 |
| 30 | GATA1_22025678_ChIP-Seq_K562_Human | 2.02036080 |
| 31 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.99534507 |
| 32 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.96515833 |
| 33 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.93396663 |
| 34 | MYB_26560356_Chip-Seq_TH2_Human | 1.91976188 |
| 35 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.82586566 |
| 36 | MAF_26560356_Chip-Seq_TH1_Human | 1.78736411 |
| 37 | MYC_22102868_ChIP-Seq_BL_Human | 1.78339409 |
| 38 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.76572337 |
| 39 | MYB_26560356_Chip-Seq_TH1_Human | 1.74349935 |
| 40 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.73801502 |
| 41 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.67010400 |
| 42 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.60609746 |
| 43 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.58100629 |
| 44 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.55385102 |
| 45 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.54866460 |
| 46 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.53211312 |
| 47 | UTX_26944678_Chip-Seq_JUKART_Human | 1.52653629 |
| 48 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.51274765 |
| 49 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.50601414 |
| 50 | * LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.50139620 |
| 51 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.50036458 |
| 52 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.49572577 |
| 53 | SPI1_23127762_ChIP-Seq_K562_Human | 1.49424758 |
| 54 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.49325111 |
| 55 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.44107874 |
| 56 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.43046422 |
| 57 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.40610023 |
| 58 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.39582166 |
| 59 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.39308266 |
| 60 | GATA1_19941826_ChIP-Seq_K562_Human | 1.37026135 |
| 61 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.33716522 |
| 62 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.30987071 |
| 63 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.29721530 |
| 64 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.29467991 |
| 65 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.24266753 |
| 66 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.20081813 |
| 67 | GATA2_19941826_ChIP-Seq_K562_Human | 1.16887291 |
| 68 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.13865585 |
| 69 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.13857104 |
| 70 | MAF_26560356_Chip-Seq_TH2_Human | 1.13786850 |
| 71 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.12202439 |
| 72 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.11602968 |
| 73 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.11529832 |
| 74 | * PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.10189347 |
| 75 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.09422981 |
| 76 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.09070660 |
| 77 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.08179095 |
| 78 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.06773733 |
| 79 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.06426076 |
| 80 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.02434024 |
| 81 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.01405634 |
| 82 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.01275374 |
| 83 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.01000302 |
| 84 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.99823983 |
| 85 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.99270004 |
| 86 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.97631957 |
| 87 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.97201010 |
| 88 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 0.96809376 |
| 89 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.96031933 |
| 90 | * GATA3_26560356_Chip-Seq_TH2_Human | 0.95992331 |
| 91 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.93490751 |
| 92 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.93067914 |
| 93 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.92625480 |
| 94 | * PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.92607658 |
| 95 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.90915503 |
| 96 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.88732941 |
| 97 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.88439355 |
| 98 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.88330067 |
| 99 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.88111505 |
| 100 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.84182869 |
| 101 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.83836051 |
| 102 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.82475285 |
| 103 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.81838004 |
| 104 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.81448246 |
| 105 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.80842470 |
| 106 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.80277676 |
| 107 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.79364943 |
| 108 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 0.78668074 |
| 109 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.78383775 |
| 110 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.75993886 |
| 111 | P300_27268052_Chip-Seq_Bcells_Human | 0.74361825 |
| 112 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.74295002 |
| 113 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.73786097 |
| 114 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.73111544 |
| 115 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.71503910 |
| 116 | VDR_23849224_ChIP-Seq_CD4+_Human | 0.71270189 |
| 117 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.71174555 |
| 118 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.68715688 |
| 119 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.67807172 |
| 120 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.65915222 |
| 121 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.65784274 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0009785_altered_susceptibility_to | 3.70947641 |
| 2 | MP0001835_abnormal_antigen_presentation | 3.61280076 |
| 3 | MP0003436_decreased_susceptibility_to | 3.53155204 |
| 4 | MP0003724_increased_susceptibility_to | 3.24369163 |
| 5 | MP0003303_peritoneal_inflammation | 3.19032533 |
| 6 | MP0002148_abnormal_hypersensitivity_rea | 3.00281022 |
| 7 | * MP0002419_abnormal_innate_immunity | 2.99121950 |
| 8 | MP0005000_abnormal_immune_tolerance | 2.86538281 |
| 9 | MP0005025_abnormal_response_to | 2.83738704 |
| 10 | MP0004510_myositis | 2.59167983 |
| 11 | MP0006082_CNS_inflammation | 2.55399453 |
| 12 | MP0009278_abnormal_bone_marrow | 2.53908328 |
| 13 | MP0005671_abnormal_response_to | 2.52392101 |
| 14 | MP0001800_abnormal_humoral_immune | 2.52341267 |
| 15 | * MP0002452_abnormal_antigen_presenting | 2.51166124 |
| 16 | MP0005387_immune_system_phenotype | 2.49525099 |
| 17 | MP0001790_abnormal_immune_system | 2.49525099 |
| 18 | MP0005464_abnormal_platelet_physiology | 2.48328352 |
| 19 | * MP0000685_abnormal_immune_system | 2.42689715 |
| 20 | * MP0002723_abnormal_immune_serum | 2.39928436 |
| 21 | * MP0002420_abnormal_adaptive_immunity | 2.23579248 |
| 22 | * MP0001819_abnormal_immune_cell | 2.23366156 |
| 23 | MP0001545_abnormal_hematopoietic_system | 2.22400907 |
| 24 | MP0005397_hematopoietic_system_phenotyp | 2.22400907 |
| 25 | MP0001533_abnormal_skeleton_physiology | 2.06347039 |
| 26 | MP0002405_respiratory_system_inflammati | 1.99450360 |
| 27 | MP0004808_abnormal_hematopoietic_stem | 1.98179816 |
| 28 | MP0004947_skin_inflammation | 1.95689278 |
| 29 | MP0008260_abnormal_autophagy | 1.88703214 |
| 30 | * MP0001845_abnormal_inflammatory_respons | 1.84924025 |
| 31 | MP0002006_tumorigenesis | 1.84905619 |
| 32 | MP0000343_altered_response_to | 1.83030397 |
| 33 | MP0002398_abnormal_bone_marrow | 1.81786033 |
| 34 | MP0010155_abnormal_intestine_physiology | 1.76856750 |
| 35 | * MP0000716_abnormal_immune_system | 1.74114411 |
| 36 | MP0005058_abnormal_lysosome_morphology | 1.73310431 |
| 37 | MP0001853_heart_inflammation | 1.63489009 |
| 38 | MP0000858_altered_metastatic_potential | 1.57123166 |
| 39 | MP0002396_abnormal_hematopoietic_system | 1.55879666 |
| 40 | MP0000689_abnormal_spleen_morphology | 1.54359721 |
| 41 | MP0008469_abnormal_protein_level | 1.53403628 |
| 42 | * MP0002429_abnormal_blood_cell | 1.48881405 |
| 43 | MP0000465_gastrointestinal_hemorrhage | 1.48612567 |
| 44 | MP0003448_altered_tumor_morphology | 1.47729322 |
| 45 | MP0009333_abnormal_splenocyte_physiolog | 1.44724124 |
| 46 | * MP0002722_abnormal_immune_system | 1.43247584 |
| 47 | MP0009764_decreased_sensitivity_to | 1.43239180 |
| 48 | MP0002166_altered_tumor_susceptibility | 1.42963934 |
| 49 | MP0003172_abnormal_lysosome_physiology | 1.40505546 |
| 50 | MP0002132_abnormal_respiratory_system | 1.39721308 |
| 51 | MP0008004_abnormal_stomach_pH | 1.38333411 |
| 52 | MP0001851_eye_inflammation | 1.38193353 |
| 53 | MP0005174_abnormal_tail_pigmentation | 1.35168453 |
| 54 | MP0002254_reproductive_system_inflammat | 1.31757722 |
| 55 | MP0005167_abnormal_blood-brain_barrier | 1.31457013 |
| 56 | MP0003075_altered_response_to | 1.30141204 |
| 57 | MP0001873_stomach_inflammation | 1.26553951 |
| 58 | MP0000490_abnormal_crypts_of | 1.21835918 |
| 59 | MP0002933_joint_inflammation | 1.21419424 |
| 60 | MP0005310_abnormal_salivary_gland | 1.19359135 |
| 61 | * MP0002998_abnormal_bone_remodeling | 1.18334559 |
| 62 | MP0003763_abnormal_thymus_physiology | 1.18142320 |
| 63 | MP0003300_gastrointestinal_ulcer | 1.17334099 |
| 64 | MP0005451_abnormal_body_composition | 1.16332822 |
| 65 | MP0010352_gastrointestinal_tract_polyps | 1.15379608 |
| 66 | MP0003690_abnormal_glial_cell | 1.12883318 |
| 67 | MP0002277_abnormal_respiratory_mucosa | 1.09957191 |
| 68 | MP0003186_abnormal_redox_activity | 1.08654649 |
| 69 | MP0005076_abnormal_cell_differentiation | 1.06099878 |
| 70 | MP0005390_skeleton_phenotype | 1.05810222 |
| 71 | MP0003183_abnormal_peptide_metabolism | 1.03384459 |
| 72 | MP0005023_abnormal_wound_healing | 0.99397745 |
| 73 | MP0003828_pulmonary_edema | 0.99294118 |
| 74 | MP0004381_abnormal_hair_follicle | 0.95811269 |
| 75 | MP0000604_amyloidosis | 0.95173157 |
| 76 | MP0002009_preneoplasia | 0.94901391 |
| 77 | MP0005164_abnormal_response_to | 0.94821687 |
| 78 | MP0008438_abnormal_cutaneous_collagen | 0.92228257 |
| 79 | MP0003566_abnormal_cell_adhesion | 0.91800883 |
| 80 | MP0000703_abnormal_thymus_morphology | 0.89236337 |
| 81 | MP0010307_abnormal_tumor_latency | 0.89082186 |
| 82 | MP0001958_emphysema | 0.86946834 |
| 83 | MP0009763_increased_sensitivity_to | 0.86156319 |
| 84 | MP0003866_abnormal_defecation | 0.86142799 |
| 85 | MP0002877_abnormal_melanocyte_morpholog | 0.84941053 |
| 86 | MP0005166_decreased_susceptibility_to | 0.83953823 |
| 87 | MP0008057_abnormal_DNA_replication | 0.83732502 |
| 88 | MP0004130_abnormal_muscle_cell | 0.83684961 |
| 89 | MP0002019_abnormal_tumor_incidence | 0.82322620 |
| 90 | MP0000249_abnormal_blood_vessel | 0.81736560 |
| 91 | MP0002332_abnormal_exercise_endurance | 0.80700581 |
| 92 | MP0009765_abnormal_xenobiotic_induced | 0.79246460 |
| 93 | MP0003453_abnormal_keratinocyte_physiol | 0.77943979 |
| 94 | MP0005075_abnormal_melanosome_morpholog | 0.76344811 |
| 95 | MP0004484_altered_response_of | 0.75613881 |
| 96 | MP0003091_abnormal_cell_migration | 0.74666184 |
| 97 | MP0003191_abnormal_cellular_cholesterol | 0.74345200 |
| 98 | MP0003045_fibrosis | 0.74078094 |
| 99 | MP0006054_spinal_hemorrhage | 0.72595084 |
| 100 | MP0003221_abnormal_cardiomyocyte_apopto | 0.72324726 |
| 101 | * MP0003795_abnormal_bone_structure | 0.69577493 |
| 102 | MP0000371_diluted_coat_color | 0.66846640 |
| 103 | MP0000767_abnormal_smooth_muscle | 0.66060574 |
| 104 | MP0003705_abnormal_hypodermis_morpholog | 0.66036811 |
| 105 | MP0009840_abnormal_foam_cell | 0.65569665 |
| 106 | MP0002133_abnormal_respiratory_system | 0.63784026 |
| 107 | MP0005388_respiratory_system_phenotype | 0.63784026 |
| 108 | MP0000569_abnormal_digit_pigmentation | 0.60489599 |
| 109 | MP0004883_abnormal_blood_vessel | 0.60013797 |
| 110 | MP0003806_abnormal_nucleotide_metabolis | 0.59261789 |
| 111 | MP0001191_abnormal_skin_condition | 0.58395715 |
| 112 | MP0002138_abnormal_hepatobiliary_system | 0.58363649 |
| 113 | MP0003656_abnormal_erythrocyte_physiolo | 0.57471635 |
| 114 | MP0008873_increased_physiological_sensi | 0.57199852 |
| 115 | MP0003693_abnormal_embryo_hatching | 0.56250451 |
| 116 | MP0000313_abnormal_cell_death | 0.55950449 |
| 117 | MP0001663_abnormal_digestive_system | 0.55599436 |
| 118 | MP0000015_abnormal_ear_pigmentation | 0.54868800 |
| 119 | MP0009931_abnormal_skin_appearance | 0.54045662 |
| 120 | MP0005376_homeostasis/metabolism_phenot | 0.53471690 |
| 121 | MP0008874_decreased_physiological_sensi | 0.51307554 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 7.12123803 |
| 2 | Eczematoid dermatitis (HP:0000976) | 6.62864083 |
| 3 | Recurrent bacterial skin infections (HP:0005406) | 6.41458221 |
| 4 | Recurrent gram-negative bacterial infections (HP:0005420) | 5.55244111 |
| 5 | Mediastinal lymphadenopathy (HP:0100721) | 4.81410864 |
| 6 | Abnormality of macrophages (HP:0004311) | 4.69203780 |
| 7 | Myositis (HP:0100614) | 4.42600393 |
| 8 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.34483504 |
| 9 | Stomatitis (HP:0010280) | 4.25433966 |
| 10 | Obstructive lung disease (HP:0006536) | 4.13492558 |
| 11 | Chronic obstructive pulmonary disease (HP:0006510) | 4.13492558 |
| 12 | Orchitis (HP:0100796) | 4.02585294 |
| 13 | Recurrent skin infections (HP:0001581) | 3.93409519 |
| 14 | Cellulitis (HP:0100658) | 3.84877720 |
| 15 | Gingivitis (HP:0000230) | 3.75631566 |
| 16 | Optic neuritis (HP:0100653) | 3.73320772 |
| 17 | Retrobulbar optic neuritis (HP:0100654) | 3.73320772 |
| 18 | Recurrent fungal infections (HP:0002841) | 3.59414775 |
| 19 | Petechiae (HP:0000967) | 3.50528616 |
| 20 | Autoimmune thrombocytopenia (HP:0001973) | 3.46914827 |
| 21 | Thrombocytosis (HP:0001894) | 3.45557571 |
| 22 | Vasculitis (HP:0002633) | 3.31409768 |
| 23 | Amyloidosis (HP:0011034) | 3.27412615 |
| 24 | Abnormality of the nasal mucosa (HP:0000433) | 3.16359524 |
| 25 | Periodontitis (HP:0000704) | 3.14828519 |
| 26 | Urticaria (HP:0001025) | 3.14658576 |
| 27 | Spontaneous hematomas (HP:0007420) | 3.13286012 |
| 28 | Meningitis (HP:0001287) | 3.12290689 |
| 29 | Recurrent viral infections (HP:0004429) | 3.09949968 |
| 30 | Nasal polyposis (HP:0100582) | 3.06317180 |
| 31 | Prolonged bleeding time (HP:0003010) | 2.97212942 |
| 32 | T lymphocytopenia (HP:0005403) | 2.95291843 |
| 33 | Chronic otitis media (HP:0000389) | 2.91379057 |
| 34 | Abnormality of T cell number (HP:0011839) | 2.90604032 |
| 35 | Peritonitis (HP:0002586) | 2.86844831 |
| 36 | Vacuolated lymphocytes (HP:0001922) | 2.85307686 |
| 37 | Interstitial pulmonary disease (HP:0006530) | 2.84637647 |
| 38 | Hematochezia (HP:0002573) | 2.80707032 |
| 39 | Epistaxis (HP:0000421) | 2.79327255 |
| 40 | Episodic fever (HP:0001954) | 2.77840817 |
| 41 | Pustule (HP:0200039) | 2.73583021 |
| 42 | Gingival bleeding (HP:0000225) | 2.71349278 |
| 43 | Vertebral compression fractures (HP:0002953) | 2.68280566 |
| 44 | Arterial thrombosis (HP:0004420) | 2.66118782 |
| 45 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.64944188 |
| 46 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.64944188 |
| 47 | Abnormality of glycolipid metabolism (HP:0010969) | 2.64944188 |
| 48 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.62877998 |
| 49 | Granulocytopenia (HP:0001913) | 2.60378084 |
| 50 | Increased cerebral lipofuscin (HP:0011813) | 2.59181606 |
| 51 | Pulmonary embolism (HP:0002204) | 2.58367129 |
| 52 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.56592373 |
| 53 | Osteomyelitis (HP:0002754) | 2.55844878 |
| 54 | Pulmonary infiltrates (HP:0002113) | 2.53285680 |
| 55 | Panhypogammaglobulinemia (HP:0003139) | 2.51748888 |
| 56 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.50750386 |
| 57 | IgM deficiency (HP:0002850) | 2.50702809 |
| 58 | Recurrent bronchitis (HP:0002837) | 2.49312931 |
| 59 | Systemic lupus erythematosus (HP:0002725) | 2.47551443 |
| 60 | Tetraparesis (HP:0002273) | 2.46686266 |
| 61 | Purpura (HP:0000979) | 2.46081663 |
| 62 | Leukocytosis (HP:0001974) | 2.45457230 |
| 63 | Gangrene (HP:0100758) | 2.42098841 |
| 64 | Anorexia (HP:0002039) | 2.40761732 |
| 65 | Recurrent cutaneous fungal infections (HP:0011370) | 2.38087817 |
| 66 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.38087817 |
| 67 | Keratoconjunctivitis sicca (HP:0001097) | 2.35381559 |
| 68 | Gastrointestinal stroma tumor (HP:0100723) | 2.33415647 |
| 69 | Agnosia (HP:0010524) | 2.30273137 |
| 70 | Inflammation of the large intestine (HP:0002037) | 2.29663985 |
| 71 | Abnormality of T cell physiology (HP:0011840) | 2.29599558 |
| 72 | Recurrent pneumonia (HP:0006532) | 2.28908981 |
| 73 | Hemoptysis (HP:0002105) | 2.28606625 |
| 74 | Recurrent lower respiratory tract infections (HP:0002783) | 2.28075660 |
| 75 | Vertigo (HP:0002321) | 2.27344868 |
| 76 | Chest pain (HP:0100749) | 2.26873844 |
| 77 | Eosinophilia (HP:0001880) | 2.26394300 |
| 78 | Abnormality of the pleura (HP:0002103) | 2.24971792 |
| 79 | Gastrointestinal inflammation (HP:0004386) | 2.20689705 |
| 80 | Abnormality of the peritoneum (HP:0002585) | 2.18787566 |
| 81 | Colitis (HP:0002583) | 2.17856337 |
| 82 | Abnormal platelet volume (HP:0011876) | 2.12407714 |
| 83 | Basal ganglia calcification (HP:0002135) | 2.11895053 |
| 84 | Sepsis (HP:0100806) | 2.11818749 |
| 85 | Keratoconjunctivitis (HP:0001096) | 2.11198151 |
| 86 | Viral hepatitis (HP:0006562) | 2.10924320 |
| 87 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.10303247 |
| 88 | Hypergammaglobulinemia (HP:0010702) | 2.10220535 |
| 89 | Autoimmune hemolytic anemia (HP:0001890) | 2.09675421 |
| 90 | Amaurosis fugax (HP:0100576) | 2.06824537 |
| 91 | Hypochromic anemia (HP:0001931) | 2.05436186 |
| 92 | Abnormality of the endocardium (HP:0004306) | 2.05128354 |
| 93 | Hypochromic microcytic anemia (HP:0004840) | 2.04503821 |
| 94 | Glomerulopathy (HP:0100820) | 2.04332552 |
| 95 | Agammaglobulinemia (HP:0004432) | 2.04183733 |
| 96 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.03855958 |
| 97 | Abnormality of iron homeostasis (HP:0011031) | 2.03592731 |
| 98 | Mucopolysacchariduria (HP:0008155) | 2.02351338 |
| 99 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.02351338 |
| 100 | Prostate neoplasm (HP:0100787) | 2.02279183 |
| 101 | Lymphopenia (HP:0001888) | 2.01575529 |
| 102 | Gastrointestinal infarctions (HP:0005244) | 2.01003023 |
| 103 | Skin ulcer (HP:0200042) | 2.00847144 |
| 104 | Increased IgM level (HP:0003496) | 2.00306168 |
| 105 | Dysostosis multiplex (HP:0000943) | 2.00185901 |
| 106 | Thrombophlebitis (HP:0004418) | 1.98909372 |
| 107 | Thick nail (HP:0001805) | 1.98792654 |
| 108 | Increased IgE level (HP:0003212) | 1.97932211 |
| 109 | Abnormality of the prostate (HP:0008775) | 1.96868352 |
| 110 | Impaired platelet aggregation (HP:0003540) | 1.96454136 |
| 111 | Abnormal platelet function (HP:0011869) | 1.96454136 |
| 112 | Myocardial infarction (HP:0001658) | 1.96060293 |
| 113 | Polyneuropathy (HP:0001271) | 1.94220401 |
| 114 | Microcytic anemia (HP:0001935) | 1.93078720 |
| 115 | Emphysema (HP:0002097) | 1.92631063 |
| 116 | Encephalitis (HP:0002383) | 1.91486930 |
| 117 | Hepatosplenomegaly (HP:0001433) | 1.90358734 |
| 118 | Deformed sella turcica (HP:0002681) | 1.89462719 |
| 119 | Acute hepatic failure (HP:0006554) | 1.88072432 |
| 120 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.87736532 |
| 121 | Osteolytic defects of the hand bones (HP:0009699) | 1.87176495 |
| 122 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.87176495 |
| 123 | Glomerulonephritis (HP:0000099) | 1.86017268 |
| 124 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.84267738 |
| 125 | Abnormality of the pericardium (HP:0001697) | 1.83089129 |
| 126 | Fatigue (HP:0012378) | 1.83046317 |
| 127 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.82984278 |
| 128 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.82984278 |
| 129 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.82984278 |
| 130 | Premature loss of primary teeth (HP:0006323) | 1.82586800 |
| 131 | J-shaped sella turcica (HP:0002680) | 1.81703674 |
| 132 | Abnormality of T cells (HP:0002843) | 1.81367076 |
| 133 | Recurrent sinusitis (HP:0011108) | 1.80265136 |
| 134 | Increased serum ferritin (HP:0003281) | 1.80034162 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RIPK4 | 4.29314506 |
| 2 | BLK | 3.54998980 |
| 3 | IRAK4 | 3.16740919 |
| 4 | MAP3K14 | 3.08974183 |
| 5 | MAP4K1 | 2.97583726 |
| 6 | KIT | 2.95348804 |
| 7 | TBK1 | 2.75365346 |
| 8 | IRAK3 | 2.72690485 |
| 9 | MAP2K3 | 2.69319054 |
| 10 | IKBKB | 2.30424247 |
| 11 | ERN1 | 2.27192181 |
| 12 | IKBKE | 2.24572762 |
| 13 | PRPF4B | 2.15957897 |
| 14 | TYK2 | 2.13786561 |
| 15 | JAK3 | 2.09004958 |
| 16 | TGFBR2 | 1.93463354 |
| 17 | STK10 | 1.91035946 |
| 18 | TXK | 1.84469546 |
| 19 | ZAP70 | 1.80133829 |
| 20 | BTK | 1.78258200 |
| 21 | PIM2 | 1.67397941 |
| 22 | MATK | 1.61923423 |
| 23 | CSK | 1.58202263 |
| 24 | TEC | 1.53086539 |
| 25 | TNK2 | 1.52973856 |
| 26 | RPS6KA4 | 1.51863722 |
| 27 | PIM1 | 1.44428986 |
| 28 | SYK | 1.41934324 |
| 29 | IRAK1 | 1.37372586 |
| 30 | NME2 | 1.36020731 |
| 31 | TRIB3 | 1.35525046 |
| 32 | CHUK | 1.29370903 |
| 33 | MAP3K3 | 1.28638426 |
| 34 | TGFBR1 | 1.28253653 |
| 35 | LRRK2 | 1.26198691 |
| 36 | CSF1R | 1.21535908 |
| 37 | PBK | 1.20723567 |
| 38 | MAP3K13 | 1.19893704 |
| 39 | JAK1 | 1.19646762 |
| 40 | HCK | 1.17830847 |
| 41 | IRAK2 | 1.14775470 |
| 42 | ITK | 1.12999727 |
| 43 | LYN | 1.12454472 |
| 44 | TESK1 | 1.08866335 |
| 45 | MARK3 | 1.08571494 |
| 46 | TESK2 | 1.06642410 |
| 47 | EPHB1 | 1.06577541 |
| 48 | TAOK1 | 1.05285306 |
| 49 | LCK | 0.99344489 |
| 50 | FES | 0.98407147 |
| 51 | PRKG2 | 0.94327793 |
| 52 | MAP3K11 | 0.86940802 |
| 53 | MAP3K2 | 0.84444401 |
| 54 | JAK2 | 0.84035424 |
| 55 | MAP3K12 | 0.82981569 |
| 56 | TAOK3 | 0.82524313 |
| 57 | STK4 | 0.82121205 |
| 58 | NLK | 0.81643736 |
| 59 | NEK2 | 0.81548092 |
| 60 | EIF2AK2 | 0.81132668 |
| 61 | YES1 | 0.80182497 |
| 62 | MST4 | 0.79341812 |
| 63 | MARK2 | 0.77816089 |
| 64 | KSR2 | 0.76894196 |
| 65 | CDK12 | 0.76519639 |
| 66 | MAPK7 | 0.75980536 |
| 67 | PDPK1 | 0.72716091 |
| 68 | MAPK12 | 0.72383578 |
| 69 | GRK7 | 0.71860833 |
| 70 | CDK4 | 0.71291568 |
| 71 | PTK2B | 0.71057877 |
| 72 | KDR | 0.69893571 |
| 73 | NEK9 | 0.67758103 |
| 74 | MAP3K6 | 0.66870441 |
| 75 | WEE1 | 0.66240862 |
| 76 | FGR | 0.65777570 |
| 77 | DAPK2 | 0.63812441 |
| 78 | HIPK2 | 0.61236650 |
| 79 | GRK6 | 0.60425424 |
| 80 | PAK4 | 0.60410684 |
| 81 | CLK1 | 0.59508088 |
| 82 | TAOK2 | 0.59295513 |
| 83 | MAP3K7 | 0.59172235 |
| 84 | WNK1 | 0.57588276 |
| 85 | MAP2K4 | 0.57094895 |
| 86 | CDC42BPA | 0.55516517 |
| 87 | SGK3 | 0.55439307 |
| 88 | MOS | 0.55207130 |
| 89 | ABL1 | 0.55107925 |
| 90 | TIE1 | 0.54967789 |
| 91 | FYN | 0.53258950 |
| 92 | PRKCD | 0.52491227 |
| 93 | ALK | 0.51931621 |
| 94 | EGFR | 0.51822455 |
| 95 | CDK6 | 0.51669349 |
| 96 | MAP3K10 | 0.51416390 |
| 97 | SGK2 | 0.50417994 |
| 98 | BMX | 0.49547877 |
| 99 | TRPM7 | 0.49348886 |
| 100 | SIK3 | 0.48832590 |
| 101 | EEF2K | 0.48815890 |
| 102 | MAPK4 | 0.47249345 |
| 103 | SRPK1 | 0.47234025 |
| 104 | PRKCQ | 0.46846387 |
| 105 | RET | 0.46017299 |
| 106 | MAP3K5 | 0.45814458 |
| 107 | TTN | 0.45749456 |
| 108 | MAPKAPK2 | 0.45686370 |
| 109 | BRSK2 | 0.45171586 |
| 110 | PKN2 | 0.45082447 |
| 111 | CDK19 | 0.44654984 |
| 112 | MAP3K1 | 0.44329292 |
| 113 | ABL2 | 0.43612886 |
| 114 | PRKD2 | 0.42770533 |
| 115 | CDK7 | 0.42753798 |
| 116 | EPHA3 | 0.41041366 |
| 117 | RPS6KA6 | 0.40684680 |
| 118 | CAMKK2 | 0.40528670 |
| 119 | STK11 | 0.39964191 |
| 120 | MAP2K6 | 0.39552349 |
| 121 | BMPR2 | 0.38981365 |
| 122 | PDK1 | 0.38773075 |
| 123 | STK3 | 0.36211537 |
| 124 | PTK6 | 0.36205113 |
| 125 | PIK3CG | 0.36177083 |
| 126 | RPS6KB2 | 0.35650468 |
| 127 | ATR | 0.34996891 |
| 128 | EIF2AK3 | 0.34121140 |
| 129 | PDGFRB | 0.33381852 |
| 130 | RAF1 | 0.32369071 |
| 131 | DYRK1B | 0.31019312 |
| 132 | MAP3K8 | 0.30502068 |
| 133 | FRK | 0.30092413 |
| 134 | FGFR3 | 0.29874075 |
| 135 | FLT3 | 0.28747388 |
| 136 | SIK2 | 0.28085362 |
| 137 | RPS6KC1 | 0.27995899 |
| 138 | RPS6KL1 | 0.27995899 |
| 139 | PRKAA2 | 0.26845886 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Leishmaniasis_Homo sapiens_hsa05140 | 3.60432934 |
| 2 | Asthma_Homo sapiens_hsa05310 | 2.98854287 |
| 3 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.61159109 |
| 4 | Legionellosis_Homo sapiens_hsa05134 | 2.55783419 |
| 5 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.45546539 |
| 6 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.40678566 |
| 7 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.39884440 |
| 8 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.37351310 |
| 9 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.37323653 |
| 10 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.34787909 |
| 11 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.30067742 |
| 12 | Malaria_Homo sapiens_hsa05144 | 2.23552844 |
| 13 | Pertussis_Homo sapiens_hsa05133 | 2.12790599 |
| 14 | Allograft rejection_Homo sapiens_hsa05330 | 2.10380828 |
| 15 | Measles_Homo sapiens_hsa05162 | 2.02618082 |
| 16 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.97771411 |
| 17 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.96531147 |
| 18 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.95634739 |
| 19 | Tuberculosis_Homo sapiens_hsa05152 | 1.90217560 |
| 20 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.82561364 |
| 21 | Salmonella infection_Homo sapiens_hsa05132 | 1.69989977 |
| 22 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.65687191 |
| 23 | Influenza A_Homo sapiens_hsa05164 | 1.62078576 |
| 24 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.56979525 |
| 25 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.51144177 |
| 26 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.48408943 |
| 27 | Shigellosis_Homo sapiens_hsa05131 | 1.46387155 |
| 28 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.46168138 |
| 29 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.45839708 |
| 30 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.41432872 |
| 31 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.40867202 |
| 32 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.36686359 |
| 33 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.34282410 |
| 34 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.30138038 |
| 35 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.28765266 |
| 36 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.28752196 |
| 37 | Apoptosis_Homo sapiens_hsa04210 | 1.26652620 |
| 38 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.23980986 |
| 39 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.23805747 |
| 40 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.21696428 |
| 41 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.18741305 |
| 42 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.17202322 |
| 43 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.14073160 |
| 44 | Other glycan degradation_Homo sapiens_hsa00511 | 1.10862913 |
| 45 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.09756735 |
| 46 | Phagosome_Homo sapiens_hsa04145 | 1.08986598 |
| 47 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.07044730 |
| 48 | Lysosome_Homo sapiens_hsa04142 | 1.06706857 |
| 49 | Hepatitis B_Homo sapiens_hsa05161 | 1.04698852 |
| 50 | Platelet activation_Homo sapiens_hsa04611 | 1.00028368 |
| 51 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.95748248 |
| 52 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.95496347 |
| 53 | Ribosome_Homo sapiens_hsa03010 | 0.89734435 |
| 54 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.88764891 |
| 55 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.87342034 |
| 56 | DNA replication_Homo sapiens_hsa03030 | 0.85961429 |
| 57 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.85328388 |
| 58 | Amoebiasis_Homo sapiens_hsa05146 | 0.85172253 |
| 59 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.83189421 |
| 60 | Hepatitis C_Homo sapiens_hsa05160 | 0.78416049 |
| 61 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.77736553 |
| 62 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.75611844 |
| 63 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.75312813 |
| 64 | * Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.73639852 |
| 65 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.70430376 |
| 66 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.69213329 |
| 67 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.69002277 |
| 68 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.68165910 |
| 69 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.65484318 |
| 70 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.65434047 |
| 71 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.63047709 |
| 72 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.60907581 |
| 73 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.60649366 |
| 74 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.60341380 |
| 75 | Base excision repair_Homo sapiens_hsa03410 | 0.59961249 |
| 76 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.58068621 |
| 77 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.57826370 |
| 78 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.56932081 |
| 79 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.56218227 |
| 80 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.55254350 |
| 81 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.54843968 |
| 82 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.54838556 |
| 83 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.54237647 |
| 84 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.52974672 |
| 85 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.52923585 |
| 86 | Viral myocarditis_Homo sapiens_hsa05416 | 0.52889719 |
| 87 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.52618625 |
| 88 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.49125074 |
| 89 | Endocytosis_Homo sapiens_hsa04144 | 0.48076650 |
| 90 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.47510963 |
| 91 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.45104291 |
| 92 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.44794580 |
| 93 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.44324078 |
| 94 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.43839647 |
| 95 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.42900537 |
| 96 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.42253700 |
| 97 | Endometrial cancer_Homo sapiens_hsa05213 | 0.41416518 |
| 98 | HTLV-I infection_Homo sapiens_hsa05166 | 0.40778313 |
| 99 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.40505746 |
| 100 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.37857951 |
| 101 | Mismatch repair_Homo sapiens_hsa03430 | 0.36883315 |
| 102 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.36116793 |
| 103 | Proteasome_Homo sapiens_hsa03050 | 0.35219914 |
| 104 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.34960726 |
| 105 | Colorectal cancer_Homo sapiens_hsa05210 | 0.33944600 |
| 106 | Prion diseases_Homo sapiens_hsa05020 | 0.32224212 |
| 107 | Prostate cancer_Homo sapiens_hsa05215 | 0.32081863 |
| 108 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.30913285 |
| 109 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.30592388 |
| 110 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.29834576 |
| 111 | Insulin resistance_Homo sapiens_hsa04931 | 0.29324447 |
| 112 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.28050988 |
| 113 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.27009158 |
| 114 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.27004798 |
| 115 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.26716750 |
| 116 | Homologous recombination_Homo sapiens_hsa03440 | 0.26547704 |
| 117 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.26348208 |
| 118 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.25766117 |
| 119 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.23408033 |
| 120 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.22895566 |
| 121 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.22865993 |
| 122 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.21814232 |
| 123 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.20578507 |

